Article info

Download PDFPDF

Editorial
JAK inhibition and the holy grail for pain control in early RA

Authors

  • Sofia Pazmino Department of Development and Regeneration, Skeletal Biology and Engineering Research Centre, KU Leuven, Leuven, Vlaams-Brabant, Belgium PubMed articlesGoogle scholar articles
  • Patrick Verschueren Rheumatology, KU Leuven University Hospitals Leuven, Leuven, BelgiumSkeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven Biomedical Sciences Group, Leuven, Belgium PubMed articlesGoogle scholar articles
  • René Westhovens Skeletal Biology and Engineering Research Centre, Department of Development and Regeneration, KU Leuven, Leuven, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Dr René Westhovens; rene.westhovens{at}uzleuven.be
View Full Text

Citation

Pazmino S, Verschueren P, Westhovens R
JAK inhibition and the holy grail for pain control in early RA

Publication history

  • Received December 2, 2021
  • Accepted January 17, 2022
  • First published January 28, 2022.
Online issue publication 
June 08, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.